Symmetry Medical Inc.  

(Public, NYSE:SMA)   Watch this stock  
Find more results for length
8.89
-0.02 (-0.22%)
Real-time:   1:04PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 8.89 - 9.06
52 week 7.69 - 11.11
Open 8.95
Vol / Avg. 65,114.00/118,855.00
Mkt cap 333.31M
P/E     -
Div/yield     -
EPS -0.94
Shares 37.49M
Beta 0.90
Inst. own 93%
Jul 28, 2014
Q2 2014 Symmetry Medical Inc. Earnings Release (Estimated) Add to calendar
Jun 18, 2014
Symmetry Medical Inc at Wells Fargo Healthcare Conference
Jun 5, 2014
Symmetry Medical Inc. at Jefferies Global Healthcare Conference - Webcast
May 20, 2014
Symmetry Medical Inc. at UBS Global Healthcare Conference - Webcast
May 1, 2014
Q1 2014 Symmetry Medical Inc. Earnings Release
May 1, 2014
Q1 2014 Symmetry Medical Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 1.24% -8.95%
Operating margin 4.27% -8.20%
EBITD margin - 12.24%
Return on average assets 0.96% -6.39%
Return on average equity 1.76% -11.94%
Employees 2,560 -
CDP Score - -

Address

3724 N STATE ROAD 15
WARSAW, IN 46582
United States - Map
+1-574-2682252 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc�s Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.

Officers and directors

Craig B. Reynolds Independent Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Thomas J. Sullivan President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Fred L. Hite Chief Financial Officer, Senior Vice President
Age: 45
Bio & Compensation  - Reuters
David C. Milne Senior Vice President - Human Resources, Chief Compliance Officer, General Counsel, Corporate Secretary
Age: 45
Bio & Compensation  - Reuters
Stephen Hinora Jr. Senior Vice President - QA/RA
Bio & Compensation  - Reuters
Ronda L. Harris Chief Accounting Officer
Age: 42
Bio & Compensation  - Reuters
James S. Burns Independent Director
Age: 66
Bio & Compensation  - Reuters
Robert G. Deuster Independent Director
Age: 63
Bio & Compensation  - Reuters
John S. Krelle Independent Director
Age: 61
Bio & Compensation  - Reuters
Francis T. Nusspickel Independent Director
Age: 72
Bio & Compensation  - Reuters